{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:29:39Z","timestamp":1759969779717,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.maturitas.2005.09.008","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T07:07:40Z","timestamp":1128496060000},"page":"61-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S1","title":["Available medical choices for the management of menopause"],"prefix":"10.1016","volume":"52","author":[{"given":"Camil","family":"Castelo-Branco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Calaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Lanchares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2005.09.008_bib1","doi-asserted-by":"crossref","unstructured":"Executive Summary: Stage of Reproductive Aging Workshop (STRAW) Park City, Utah, July 2001. Menopause 2001; 8:402\u2013407.","DOI":"10.1097\/00042192-200111000-00004"},{"key":"10.1016\/j.maturitas.2005.09.008_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.maturitas.2003.11.002","article-title":"Influence of psycho-social factors on climacteric symptoms","volume":"48","author":"Binfa","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.09.008_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/01443619509015501","article-title":"Compliance with hormone replacement therapy","volume":"15","author":"Castelo-Branco","year":"1995","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.09.008_bib4","unstructured":"Taylor Nelson Sofres (TNS) Intersearch Corporation. Incidence and Persistency of Oestrogen Replacement. 17 May 2000."},{"issue":"3","key":"10.1016\/j.maturitas.2005.09.008_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00042192-200310030-00011","article-title":"Influences of hormone replacement therapy on post-menopausal women's health perceptions","volume":"10","author":"Bl\u00fcmel","year":"2003","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.maturitas.2005.09.008_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00042192-200209000-00011","article-title":"Use of hormone replacement therapy among Chilean women. A comparison between socio-economic levels","volume":"9","author":"Bl\u00fcmel","year":"2002","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.maturitas.2005.09.008_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.GME.0000075503.60230.61","article-title":"Patients's and clinicians\u2019 attitudes after the Women's Health Initiative Study","volume":"11","author":"Bl\u00fcmel","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2005.09.008_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.maturitas.2004.09.004","article-title":"Menopausal transition in Movima women, a Bolivian native-American","volume":"51","author":"Castelo-Branco","year":"2005","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.maturitas.2005.09.008_bib9","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.fertnstert.2003.09.080","article-title":"Tools for making correct decisions regarding hormone therapy. Part II. Organ response and clinical applications","volume":"81","author":"Kopernik","year":"2004","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.maturitas.2005.09.008_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0025-7753(04)74198-6","article-title":"Health-related quality of life in the Spanish women through and beyond menopause. Development and validation of the Cervantes Scale","volume":"122","author":"Palacios","year":"2004","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"10.1016\/j.maturitas.2005.09.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1521-690X(02)00087-8","article-title":"Medical choices available for management of menopause","volume":"17","author":"Farrell","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2005.09.008_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.maturitas.2004.01.011","article-title":"Relationship between psychological complaints and vasomotor symptoms during climacteric","volume":"49","author":"Bl\u00fcmel","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.09.008_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-5122(95)00991-4","article-title":"The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation","volume":"23","author":"Castelo-Branco","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.09.008_bib14","doi-asserted-by":"crossref","unstructured":"NIH State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: Management of Menopause-Related Symptoms. Ann Intern Med 2005;142(12):1003\u20131013.","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00117"},{"issue":"4","key":"10.1016\/j.maturitas.2005.09.008_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00042192-200107000-00011","article-title":"A scheme of combined oral contraceptives for women over 40","volume":"8","author":"Bl\u00fcmel","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2005.09.008_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of oestrogen plus progestin in healthy post-menopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2005.09.008_bib17","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine oestrogen in post-menopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.maturitas.2005.09.008_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.AOG.0000140688.71638.d3","article-title":"Phytoestrogens for treatment of menopausal symptoms: a systematic review","volume":"104","author":"Krebs","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2005.09.008_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.maturitas.2005.06.014","article-title":"Management of post-menopausal vaginal atrophy and atrophic vaginitis","volume":"525","author":"Castelo-Branco","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.09.008_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.maturitas.2004.04.007","article-title":"Low-dose, vaginally administered oestrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in post-menopausal women on hormone therapy","volume":"50","author":"Palacios","year":"2005","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.maturitas.2005.09.008_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.GME.0000072481.97324.7F","article-title":"Impairment of sexual activity in middle-aged women","volume":"11","author":"Bl\u00fcmel","year":"2004","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.maturitas.2005.09.008_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/0144361031000120978","article-title":"Prevalence of sexual dysfunction in a cohort of middle-age women. Influences of menopause and hormone replacement therapy","volume":"23","author":"Castelo-Branco","year":"2003","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.maturitas.2005.09.008_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5122(99)00081-X","article-title":"Quality of life after the menopause: a population study","volume":"34","author":"Blumel","year":"2000","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2005.09.008_bib24","first-page":"321","article-title":"Hormone replacement therapy and antidepressants during menopause","volume":"63","author":"Castelo-Branco","year":"1998","journal-title":"Rev Chil Obstet Ginecol"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2005.09.008_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002512-199812001-00004","article-title":"Management of osteoporosis: an overview","volume":"12","author":"Castelo-Branco","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.maturitas.2005.09.008_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00042192-199906040-00006","article-title":"Long-term compliance with oestrogen replacement therapy in surgical post-menopausal women: benefits to bone and analysis of factors associated with discontinuation","volume":"6","author":"Castelo-Branco","year":"1999","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.maturitas.2005.09.008_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1521-690X(02)00080-5","article-title":"Prevention and management of osteoporosis","volume":"17","author":"McClung","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2005.09.008_bib28","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1359\/jbmr.2000.15.10.1965","article-title":"Characterization of peri-menopausal bone loss: a prospective study","volume":"15","author":"Recker","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2005.09.008_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s001980200016","article-title":"Association of physical activity and calcium intake with the maintenance of bone mass in premenopausal women","volume":"13","author":"Uusi-Rasi","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2005.09.008_bib30","first-page":"241","article-title":"Ossein-Hydroxyapatite compounds for preventing post-menopausal bone loss. Coadjuvant use with hormone replacement therapy","volume":"44","author":"Castelo-Branco","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.maturitas.2005.09.008_bib31","first-page":"601","article-title":"Preventing post-menopausal bone loss with ossein-hydroxyapatite compounds","volume":"44","author":"Castelo-Branco","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.maturitas.2005.09.008_bib32","first-page":"875","article-title":"Bone mineral density in young hypothalamic amenorrheic women treated with oral contraceptives containing different doses of ethinyl estradiol","volume":"46","author":"Castelo-Branco","year":"2001","journal-title":"J Reprod Med"},{"key":"10.1016\/j.maturitas.2005.09.008_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0301-2115(01)00382-7","article-title":"Effect of continuous and sequential oral oestrogen-progestogen replacement regimens on post-menopausal bone loss: a two years prospective study","volume":"99","author":"Figueras","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.maturitas.2005.09.008_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJM200107053450106","article-title":"Post-menopausal hormone-replacement therapy","volume":"345","author":"Manson","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.maturitas.2005.09.008_bib35","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in post-menopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.maturitas.2005.09.008_bib36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in post-menopausal women with osteoporosis treated with raloxifene","volume":"282","author":"Ettinger","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2005.09.008_bib37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"Raloxifene and cardiovascular events in osteoporotic post-menopausal women: four-year results from the MORE (multiple outcomes of raloxifene evaluation) randomized trial","volume":"287","author":"Barrett-Connor","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.maturitas.2005.09.008_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00002018-200528080-00006","article-title":"Benefit\u2013risk assessment of raloxifene in post-menopausal osteoporosis","volume":"28","author":"Cranney","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.maturitas.2005.09.008_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s001980170147","article-title":"A meta-analysis of etidronate for the treatment of post-menopausal osteoporosis","volume":"12","author":"Cranney","year":"2001","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.maturitas.2005.09.008_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/01443610310000100097","article-title":"Alendronate daily, weekly in conventional tablets and weekly in enteric tablets. preliminary study on the effects in bone turnover markers and incidence of side effects","volume":"23","author":"Bl\u00fcmel","year":"2003","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2005.09.008_bib41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","article-title":"Prevention of nonvertebral fractures by alendronate: a meta-analysis","volume":"277","author":"Karpf","year":"1997","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.maturitas.2005.09.008_bib42","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2005.09.008_bib43","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with post-menopausal osteoporosis","volume":"282","author":"Harris","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2005.09.008_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in post-menopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2005.09.008_bib45","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1007\/s00198-004-1767-2","article-title":"Clinical effects of strontium ranelate in women with post-menopausal osteoporosis","volume":"16","author":"Delmas","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2005.09.008_bib46","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in post-menopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.maturitas.2005.09.008_bib47","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2005.09.008_bib48","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350(9084):1047\u201359.","DOI":"10.1016\/S0140-6736(97)08233-0"},{"issue":"362","key":"10.1016\/j.maturitas.2005.09.008_bib49","first-page":"419","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"9","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.maturitas.2005.09.008_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal oestrogen and oestrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2005.09.008_bib51","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in post-menopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2005.09.008_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in post-menopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"10.1016\/j.maturitas.2005.09.008_bib53","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in post-menopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2005.09.008_bib54","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0002-9149(02)02835-7","article-title":"Baseline characteristics of participants in the Raloxifene use for the heart (RUTH) trial","volume":"90","author":"Wenger","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.maturitas.2005.09.008_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3816\/CBC.2002.n.020","article-title":"The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial","volume":"3","author":"Vogel","year":"2002","journal-title":"Clin Breast Cancer"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205002550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205002550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:41:05Z","timestamp":1759912865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512205002550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":55,"alternative-id":["S0378512205002550"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.09.008","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Available medical choices for the management of menopause","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}